share_log

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

Benzinga Real-time News ·  Sep 28, 2022 08:16

$bioAffinity Technologies (BIAF.US)$ today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment